ARCA biopharma (ABIO) Stock Chart & Stock Price History → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free ABIO Stock Alerts $3.70 +0.23 (+6.63%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARCA biopharma Stock Price Performance5 Day Performance+4.23%1 Month Performance+13.50%3 Month Performance+121.56%6 Month Performance+102.19%Year-To-Date Performance+117.65%1 Year Performance+75.36% Receive ABIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ABIO Stock Chart for Sunday, June, 2, 2024 ABIO Chart by TradingView ARCA biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.47$3.70+6.63%$3.75$3.4868,758 shs$53.69 million05/30/2024$3.43$3.47+1.17%$3.51$3.3815,952 shs$50.35 million05/29/2024$3.55$3.43-3.38%$3.62$3.4021,513 shs$49.77 million05/28/2024$3.39$3.55+4.72%$3.62$3.4650,854 shs$51.51 million05/27/2024$3.39$3.39$3.52$3.2446,800 shs$49.18 million05/24/2024$3.26$3.39+3.99%$3.52$3.2446,826 shs$49.19 million Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$3.25$3.26+0.31%$3.36$3.1753,736 shs$47.30 million05/22/2024$3.24$3.25+0.31%$3.29$3.2049,319 shs$47.16 million05/21/2024$3.26$3.24-0.61%$3.32$3.2125,118 shs$47.01 million05/20/2024$3.33$3.26-2.10%$3.32$3.1890,493 shs$47.30 million05/17/2024$4.00$3.33-16.75%$4.49$3.11455,562 shs$48.32 million05/16/2024$3.72$4.00+7.53%$4.00$3.75170,125 shs$58.04 million05/15/2024$3.32$3.72+12.05%$3.79$3.43198,078 shs$53.98 million05/14/2024$3.40$3.32-2.35%$3.51$3.2168,520 shs$48.17 million05/13/2024$3.47$3.40-2.02%$3.55$3.0955,591 shs$49.32 million05/10/2024$3.37$3.47+2.91%$3.73$3.35185,333 shs$50.34 million05/09/2024$3.36$3.37+0.36%$3.46$3.3336,426 shs$48.92 million05/08/2024$3.29$3.36+2.13%$3.46$3.2740,419 shs$48.74 million05/07/2024$3.22$3.29+2.17%$3.35$3.2133,584 shs$47.74 million05/06/2024$3.26$3.22-1.23%$3.28$3.1951,795 shs$46.72 million05/03/2024$3.26$3.26$3.46$3.2516,945 shs$47.29 million05/02/2024$3.25$3.26+0.31%$3.35$3.2066,022 shs$47.30 million05/01/2024$3.49$3.25-6.88%$3.50$3.18155,833 shs$47.16 million04/30/2024$3.43$3.49+1.75%$3.58$3.34214,422 shs$50.64 million04/29/2024$3.58$3.43-4.19%$3.60$3.42229,892 shs$49.77 million04/26/2024$3.48$3.58+2.87%$3.68$3.5085,281 shs$51.91 million04/25/2024$3.63$3.48-4.13%$3.66$3.4153,994 shs$50.46 million04/24/2024$3.65$3.63-0.55%$3.73$3.6097,712 shs$52.64 million04/23/2024$3.45$3.65+5.80%$3.75$3.45211,794 shs$52.93 million04/22/2024$3.40$3.45+1.47%$3.48$3.30294,919 shs$50.03 million04/19/2024$3.25$3.40+4.62%$3.42$3.21922,511 shs$49.30 million04/18/2024$3.21$3.25+1.25%$3.32$3.13218,431 shs$47.13 million04/17/2024$3.27$3.21-1.83%$3.31$3.1395,037 shs$46.55 million04/16/2024$3.18$3.27+2.83%$3.31$3.13294,950 shs$47.42 million04/15/2024$3.23$3.18-1.55%$3.27$3.15134,500 shs$46.11 million04/12/2024$3.25$3.23-0.62%$3.31$3.15351,248 shs$46.84 million04/11/2024$3.14$3.25+3.50%$3.27$3.10153,785 shs$47.13 million04/10/2024$3.13$3.14+0.32%$3.19$3.01212,915 shs$45.53 million04/09/2024$3.00$3.13+4.33%$3.33$2.98570,607 shs$45.39 million04/08/2024$3.09$3.00-2.91%$3.10$2.95600,901 shs$43.50 millionAre You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$3.08$3.09+0.32%$3.18$2.95587,056 shs$44.81 million04/04/2024$3.25$3.08-5.23%$3.14$2.902.74 million shs$44.66 million04/03/2024$1.71$3.25+90.06%$3.88$2.8880.76 million shs$47.13 million04/02/2024$1.75$1.71-2.29%$1.75$1.6912,636 shs$24.80 million04/01/2024$1.76$1.75-0.57%$1.78$1.7515,352 shs$25.38 million03/29/2024$1.76$1.76$1.77$1.739,002 shs$25.52 million03/28/2024$1.75$1.76+0.57%$1.77$1.739,001 shs$25.52 million03/27/2024$1.71$1.75+2.34%$1.75$1.697,276 shs$25.38 million03/26/2024$1.73$1.71-1.16%$1.73$1.6928,574 shs$24.80 million03/25/2024$1.77$1.73-2.26%$1.78$1.7140,182 shs$25.09 million03/22/2024$1.78$1.77-0.56%$1.78$1.7511,152 shs$25.67 million03/21/2024$1.75$1.78+1.71%$1.80$1.7150,583 shs$25.81 million03/20/2024$1.74$1.75+0.57%$1.75$1.705,202 shs$25.38 million03/19/2024$1.72$1.74+1.16%$1.74$1.6558,061 shs$25.23 million03/18/2024$1.69$1.72+1.78%$1.72$1.6839,825 shs$24.94 million03/15/2024$1.70$1.69-0.59%$1.73$1.6846,812 shs$24.51 million03/14/2024$1.69$1.70+0.59%$1.70$1.6659,564 shs$24.65 million03/13/2024$1.66$1.69+1.81%$1.69$1.6619,299 shs$24.51 million03/12/2024$1.65$1.66+0.91%$1.67$1.6029,937 shs$24.07 million03/11/2024$1.64$1.65+0.30%$1.65$1.6013,103 shs$23.85 million03/08/2024$1.63$1.63$1.66$1.5815,920 shs$23.64 million03/07/2024$1.66$1.63-1.81%$1.71$1.6132,938 shs$23.64 million03/06/2024$1.67$1.66-0.60%$1.69$1.668,333 shs$24.07 million03/05/2024$1.68$1.67-0.60%$1.68$1.6247,673 shs$24.22 million03/04/2024$1.67$1.68+0.60%$1.75$1.6220,644 shs$24.36 million03/01/2024$1.63$1.67+2.45%$1.69$1.639,818 shs$24.22 million Related Companies: Achieve Life Sciences Stock Price Chart Alpha Teknova Stock Price Chart VolitionRx Stock Price Chart ImmuCell Stock Price Chart Aspira Women's Health Stock Price Chart OncoCyte Stock Price Chart Cardio Diagnostics Stock Price Chart Trinity Biotech Stock Price Chart Biomerica Stock Price Chart MyMD Pharmaceuticals Stock Price Chart Receive ABIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABIO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.